Tag: drug patent strategies

Explore how drug makers use product hopping and REMS abuse to block generic substitution, violating antitrust laws. Learn about key cases like NY v. Actavis and the billions in costs to consumers.

Recent-posts

Ocular Hypertension Explained: Causes, Symptoms & Treatment Options

Sep, 24 2025

Best Ventolin Alternatives: Inhalers Compared for Asthma Relief, Speed & Price

Apr, 27 2025

How to Avoid Transcription Errors from E-Prescribing Systems

Nov, 13 2025

Biosimilar Switching: What Happens When You Change from Originator

Feb, 1 2026

JAK Inhibitors: What Infections and Blood Clots to Watch For

Jan, 16 2026